Overview
Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss
Status:
Recruiting
Recruiting
Trial end date:
2022-01-01
2022-01-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operationPhase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Meir Medical CenterTreatments:
Tranexamic Acid
Criteria
Inclusion Criteria:- 20-90 years old female patients going through vaginal hysterctomy
Exclusion Criteria:
- massive bleeding during operation due to major vessles injury
- known coagulopathies
- sensitivity to tranexamic acid
- medical need in tranexamic acid administration during operation due to bleeding